Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2007 Sep;22(2):70–73. doi: 10.1007/BF02913317

Type-2 diabetes related intermediate phenotypic traits in north Indian diabetics

S K Mathur 1,✉, Piyush Chandra 2, Sandhya Mishra 3, Peeyush Ajmera 3, Praveen Sharma 3
PMCID: PMC3453813  PMID: 23105686

Abstract

Asian Indians are known to be at a higher risk of developing T2DM, but the underlying genetic factor in this population is still not well understood. T2DM is a complex genetic trait and assessment of disease related intermediate phenotypic traits is an important initial step towards any systematic genomic study. Therefore, in the present study we have assessed diabetes related intermediate phenotypic traits of insulin secretion and insulin resistance in the patients belonging to this population. The study included 157 T2DM patients of either sex ranging in age from 45–80 years and 84 non-diabetic subjects with no family history of diabetes, ranging in age from 45 to 75 years served as controls. Intermediate phenotypic traits studied were BMI, W: H ratio, fasting free fatty acid level and Insulin resistance and secretion. Diabetics were found to have significantly higher W: H ratio (p<0.001), FFA (p<0.001) and HOMA-R (p<0.001) as compared to non-diabetics. However, there was no significant difference in their BMI and HOMA-β. There was a positive correlation between FFA level and HOMA-R among diabetics, but not among controls. These findings suggest that in abdominal obesity FFA mediated insulin resistance is an important causative factor underlying T2DM in this population. Moreover, comparable HOMA-β in diabetics reflects compensatory insulin hyper secretion in these subjects. There is a need to examine relative contribution and precise nature of genetic factor in their tendency for central obesity, free fatty acidemia and insulin resistance.

Key words: Type-2 Diabetes Mellitus, intermediate phenotypic traits, North Indian, Free Fatty Acid, Insulin Resistance, HOMA-R, HOMA-β

Full Text

The Full Text of this article is available as a PDF (83.1 KB).

References

  • 1.McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337:382–6. doi: 10.1016/0140-6736(91)91164-P. [DOI] [PubMed] [Google Scholar]
  • 2.Mohan V, Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia. 1986;29:235–7. doi: 10.1007/BF00454882. [DOI] [PubMed] [Google Scholar]
  • 3.Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EM. Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res. 1987;19:84–5. doi: 10.1055/s-2007-1011745. [DOI] [PubMed] [Google Scholar]
  • 4.Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53. doi: 10.2337/diacare.27.5.1047. [DOI] [PubMed] [Google Scholar]
  • 5.Glazier A, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science. 2002;298:2345–9. doi: 10.1126/science.1076641. [DOI] [PubMed] [Google Scholar]
  • 6.Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1996;265:2037–48. doi: 10.1126/science.8091226. [DOI] [PubMed] [Google Scholar]
  • 7.Risch NJ. Searching for genetic determinants in the new millennium. Nature. 2000;405:847–56. doi: 10.1038/35015718. [DOI] [PubMed] [Google Scholar]
  • 8.Bougneres P. Genetics of obesity and type 2 diabetes: tracking pathogenic traits during the predisease period. Diabetes. 2002;51(Suppl 3):295–303. doi: 10.2337/diabetes.51.2007.S295. [DOI] [PubMed] [Google Scholar]
  • 9.National Institutes of Health. National Heart, Lung and Blood Institute and the North American Association of the Obesity. The Practical guide: identification, evaluation and treatment of overweight and obesity in adults. NIH publication number 00-4084.2000.
  • 10.Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. doi: 10.1007/BF00280883. [DOI] [PubMed] [Google Scholar]
  • 11.Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes. 1993;42:1663–72. doi: 10.2337/diabetes.42.11.1663. [DOI] [PubMed] [Google Scholar]
  • 12.McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 1992;258:766–70. doi: 10.1126/science.1439783. [DOI] [PubMed] [Google Scholar]
  • 13.Mathur S K, Chandra P, Mishra S, Ajmera P, Sharma P. Type 2 diabetes related intermediate phenotypic traits in north indian patients with diabetes. Endocr Pract. 2005;11(Suppl 1):16–16. doi: 10.1007/BF02913317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Abate N, Chandalia M, Snell PG, Grundy SM. Adipose Tissue Metabolites and Insulin Resistance in Nondiabetic Asian Indian Men. J Clin Endocrinol Metab. 2004;89(6):2750–5. doi: 10.1210/jc.2003-031843. [DOI] [PubMed] [Google Scholar]
  • 15.Misra A, Sinha S, Kumar M, Jagannathan NR, Pandey RM. Proton magnetic resonance spectroscopy study of soleus muscle in non-obese healthy and type-2 diabetic. Asian North Indian males, high intramyocellular lipid content correlates with excess body fat and abdominal obesity. Diabet Med. 2003;20(5):361–7. doi: 10.1046/j.1464-5491.2003.00932.x. [DOI] [PubMed] [Google Scholar]
  • 16.Krssak M, Falk PK, Dresner A, DiPietro L, Vogel SM, Rothman DL, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR Spectroscopy Study. Diabetologia. 1999;42:113–16. doi: 10.1007/s001250051123. [DOI] [PubMed] [Google Scholar]
  • 17.Perseghin G, Scifo P, Cobelli F, Pagliato E, Battezzati A, Arcelloni C, et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans. a1H-13 C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes. 1990;48:1600–6. doi: 10.2337/diabetes.48.8.1600. [DOI] [PubMed] [Google Scholar]
  • 18.Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes. 2001;50:1612–17. doi: 10.2337/diabetes.50.7.1612. [DOI] [PubMed] [Google Scholar]
  • 19.Randle PJ, Gerald PB, Hales CN, Newsholme EA. Glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785–89. doi: 10.1016/S0140-6736(63)91500-9. [DOI] [PubMed] [Google Scholar]
  • 20.Dresner A, Laurent D, Marcucci M. Effect of free fatty acid on glucose transport and IRS-1 associated phosphatidylinositol 3-kinase activity. J Clin Invest. 1999;103:253–9. doi: 10.1172/JCI5001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Carpentier A, Mittleman SD, Lamarche B. Acute enhancement of insulinsecretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol Endocrinol Metab. 1999;276E:1055–66. doi: 10.1152/ajpendo.1999.276.6.E1055. [DOI] [PubMed] [Google Scholar]
  • 22.Boden G, Schulman GI. Free fatty acids in obesity and diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eu J Clin Invest. 2002;32(Suppl 3):14–23. doi: 10.1046/j.1365-2362.32.s3.3.x. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES